University of Thessaly, Department of Biochemistry & Biotechnology, Larissa, Greece.
Clin Microbiol Infect. 2010 Nov;16(11):1672-5. doi: 10.1111/j.1469-0691.2010.03188.x.
In this study, the serological status of the southern Greek population in the 1–10-year, 11–20-year, 21–30-year and 31–40-year age groups with regard to Sabin vaccine strains and a collection of 15 recombinant and four non-recombinant poliovirus vaccine strains was determined. For all three poliovirus types, the highest neutralization test (NT) titres were observed in the 1–10- year age group, indicating a good response to vaccination. In general, the serological status of the population of southern Greece with regard to poliovirus is better for types 1 and 2 than for type 3. The presence of the lowest NT titre in the 21– 30-year age group against poliovirus type 3 suggests the need for a booster dose of monovalent Sabin3 vaccine to ensure personal and herd immunity.
在这项研究中,对年龄在 1-10 岁、11-20 岁、21-30 岁和 31-40 岁的希腊南部人群的血清学状况进行了研究,涉及到 Sabin 疫苗株和 15 种重组和 4 种非重组脊灰病毒疫苗株。对于所有三种脊灰病毒类型,1-10 岁年龄组的中和试验(NT)滴度最高,表明对疫苗接种有良好的反应。一般来说,希腊南部人群的脊灰病毒血清学状况在 1 型和 2 型方面要好于 3 型。在 21-30 岁年龄组中,针对脊灰病毒 3 型的 NT 滴度最低,这表明需要加强接种单价 Sabin3 疫苗,以确保个人和群体免疫力。